Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Mar;38(2):181-6.
doi: 10.3109/00952990.2011.644002. Epub 2012 Jan 5.

The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression

Affiliations
Randomized Controlled Trial

The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression

Maryam Afshar et al. Am J Drug Alcohol Abuse. 2012 Mar.

Abstract

Background: Prior findings concerning the use of mirtazapine in the treatment of a variety of substance use disorders and its antagonistic actions at the serotonin 5-HT(2A) receptor suggest that this drug may have efficacy in the treatment of cocaine dependence in the presence of a depressive disorder.

Methods: Depressed cocaine-dependent subjects received either mirtazapine (target dose 45 mg daily) or placebo for 12 weeks. Urine concentrations of benzoylecgonine and self-report were used to assess cocaine consumption. Depression and sleep quality were evaluated using the Hamilton Depression Rating Scale (HAM-D) and the Pittsburgh Sleep Quality Index, respectively.

Results: Cocaine consumption during the treatment period did not differ significantly between the mirtazapine (n = 11) and placebo (n = 13) groups in this study. In week 4 sleep latency was significantly lower in the active medication than in the placebo group. Positive effects of mirtazapine treatment on early insomnia were suggested by an item analysis of the HAM-D.

Conclusions and scientific significance: The results of this study suggest that mirtazapine is superior to placebo in improving sleep in patients with comorbid depression and cocaine dependence, but is not more effective than placebo in reducing cocaine use.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Figures

Figure 1
Figure 1
Mean (±SE) ln benzoylecgonine (BE) concentrations obtained for the screening period (week 0) and the treatment period (weeks 1–11) for the mirtazapine (MIRTZ) and placebo (PLAC) groups.
Figure 2
Figure 2
Mean (SE) sleep latency obtained for the mirtazapine (MIRTZ) and placebo (PLAC) groups at screening and weeks 4, 8, and 12. *p < .008 for the between group comparison.

References

    1. Brady KT, Grice DE, Dustan L, Randall C. Gender differences in substance use disorders. Am J Psychiatry. 1993;150(11):1707–1711. - PubMed
    1. López A, Becoña E. Depression and cocaine dependence. Psychol Rep. 2007;100(2):520–524. - PubMed
    1. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991;48(1):43–51. - PubMed
    1. Conner KR, Pinquart M, Holbrook AP. Meta-analysis of depression and substance use and impairment among cocaine users. Drug Alcohol Depend. 2008;98(1–2):13–23. - PMC - PubMed
    1. Poling J, Kosten TR, Sofuoglu M. Treatment outcome predictors for cocaine dependence. Am J Drug Alcohol Abuse. 2007;33(2):191–206. - PubMed

Publication types